Ownership and insider activity for NEXGEL, Inc. (NXGL): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations.
Price
| Price | $0.25 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 0 | 0 | $261000 | $32000 | $13.3M | $1.1M | $2.7M | $1.8M | $317000 |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | $5.5M | 0 | 0 | 0 |
| Receivables | $74000 | $99000 | $34000 | $102000 | $73000 | $209000 | $222000 | $633000 | $933000 | $673000 |
| Inventory | $158000 | $93000 | $101000 | $113000 | $233000 | $291000 | $502000 | $1.3M | $1.8M | $2.1M |
| Total Current Assets | $257000 | $199000 | $361000 | $513000 | $363000 | $13.9M | $7.5M | $5.1M | $5.1M | $4.3M |
| Property, Plant & Equipment | $831000 | $522000 | $200000 | $1.2M | $1.4M | $2.6M | $2.5M | $3.4M | $3.8M | $4.0M |
| Goodwill | 0 | 0 | 0 | 0 | $311000 | $311000 | $311000 | $1.1M | $1.1M | $1.1M |
| Intangible Assets | 0 | 0 | 0 | 0 | $47000 | $33000 | $20000 | $326000 | $807000 | $681000 |
| Total Assets | $1.3M | $894000 | $739000 | $1.9M | $2.3M | $17.0M | $10.4M | $10.0M | $11.0M | $10.5M |
| Accounts Payable | $147000 | $63000 | $157000 | $510000 | $658000 | $254000 | $265000 | $1.2M | $1.3M | $1.3M |
| Short-term Debt | 0 | 0 | 0 | 0 | $216000 | $2.0M | $15000 | $325000 | $97000 | $99000 |
| Total Current Liabilities | $384000 | $210000 | $407000 | $800000 | $1.3M | $2.9M | $859000 | $2.5M | $2.5M | $3.0M |
| Long-term Debt | 0 | 0 | 0 | 0 | $256000 | $266000 | $268000 | $513000 | $588000 | $489000 |
| Total Liabilities | $467000 | $269000 | $458000 | $1.5M | $2.2M | $4.9M | $2.7M | $4.8M | $4.9M | $5.6M |
| Retained Earnings | 0 | 0 | 0 | -$238000 | -$2.5M | -$6.8M | -$11.6M | -$14.7M | -$18.0M | -$21.0M |
| Total Equity | $794000 | $625000 | $281000 | $380000 | $71000 | $12.1M | $7.6M | $4.7M | $5.8M | $4.5M |
| Total Debt | 0 | 0 | 0 | $917000 | $1.3M | $4.3M | $2.1M | $2.8M | $2.8M | $3.1M |
| Net Debt | 0 | 0 | 0 | $656000 | $1.2M | -$9.1M | -$4.5M | $98000 | $1.0M | $2.8M |
| Working Capital | -$127000 | -$11000 | -$46000 | -$287000 | -$969000 | $11.0M | $6.6M | $2.5M | $2.6M | $1.4M |
Financial Health
| Debt / Equity | 1.51 |
| Current Ratio | 0.43 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -1.25 |
Profitability
| Return on Equity | -133.10% |
| Return on Invested Capital | -41.80% |
| Return on Assets | -23.39% |
| Gross Margin | 35.07% |
| Operating Margin | -44.77% |
| Net Margin | -51.26% |
Related companies: ENLV · FEMY · GDTC · HBIO · IINN · MLSS · MTVA
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of NXGL: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks